21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Compounds and compositions for delivering active agents
#19802Methods and compositions for oral administration of proteins
#19803Isolated ductal fluid sample
#19804METHOD OF PROVIDING READILY AVAILABLE CELLULAR MATERIAL DERIVED FROM PERIPHERAL BLOOD
#19805Medical composition for balancing bodily processes
#19806Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components
#19807Lozenge for treatment of dry mouth and related conditions
#19808Enhanced circulation effector composition and method
#19809Composition of cartilage therapeutic agents and its application
#19810INTRALUMINAL DEVICES FOR THE PREVENTION AND TREATMENT OF VASCULAR DISEASE
#19811Reiteratively layered medical devices and method of preparing same
#19812Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonist
#19813Methods of inhibiting TNFα activity in the blood of a patient
#19814Compositions and methods including a recombinant human MAB that promotes CNS remyelination
#19815Use of strains of lactobacillus and by-products thereof for inhibiting formation of blood vessels
#19816Viruses for the treatment of cellular proliferative disorders
#19817Colon cleansing compositions
#19818Method of treating dermatological conditions
#19819HAIR GROWTH COMPOSITIONS AND METHODS FOR TREATING HAIR LOSS OR RELATED CONDITIONS
#19820Miracle hair treatment
#19821Combination of medicaments for the treatment of respiratory diseases
#19822Use of l-dopa, derivatives thereof and medicaments comprising said compounds for the prophylaxis of psychotic diseases
#19823Anti cancer combinations comprising a cox-2 inhibitor
#19824Pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti-inflammatory drug
#19825Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders
#19826Methods for inhibiting protein kinases
#19827Active substance combination
#19828HIV protease inhibitors
#19829Combinations comprising ampa receptor antagonists for the treatment of schizophrenia
#19830Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
#19831Seaweed extract composition for treatment of diabetes and diabetic complications
#19832Methods and compositions for the prevention of toxic side effects of aminoglycoside medications
#19833Wound and skin care products
#19834VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
#19835Combination therapy for inhibition of platelet aggregation
#19836Compositions and methods for preparation of poorly water soluble drugs with increased stability
#19837Methods for reducing weight
#19838Glutathione and coffee suppository
#19839Traditional chinese medicine preparation for treatment of tumor and method of making and using same
#19840Catechin Adjuvants
#19841Composition for controlling the respiratory effects of inhaled pollutants & allergens
#19842Treating skin disorders
#19843Use of zeaxanthin to reduce light hyper-sensitivity, photophobia, and medical conditions relating to light hyper-sensitivity
#19844Therapeutic composition for the treatment of dry eye syndrome
#19845Nutritional or dietary supplement for the treatment of macular degeneration
#19846Risk assessment and correction of membrane damage of the upper GI tract
#19847Calcium phosphate-based materials containing zinc, magnesium, fluoride and carbonate
#19848Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene
#19849Fiber satiety compositions
#19850Fiber satiety compositions
#19851Lipid compositions and methods of use
#19852Feed formulation for terrestrial and aquatic animals
#19853Adeno-associated virus-mediated survivin mutants and methods related thereto
#19854Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
#19855Polymer-based delivery system for immunotherapy of cancer
#19856Revitalizing hair follicles with total parenteral nutrition or hyperalimentation for maximum hair growth
#19857Novel delivery of immune response modifiers for removal of chronic tattoos
#19858Pharmaceutical compositions containing botulinum toxin
#19859Composition for the treatment of bad breath
#19860Compositions comprising and methods of using norfluoxetine
#19861Methods for treating viral infections using polyamine analogs
#19862Methods and compositions for stabilizing an antioxidant
#19863Use of a fibrate and orlistat for the treatment of obesity
#19864Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
#19865Microbicidal composition
#19866Method of treatment of otitis externa
#19867COMBINATION THERAPY FOR ALZHEIMER'S DISEASE AND OTHER DISEASES
#19868Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms
#19869LPA2 receptor agonist inhibitors of CFTR
#19870Compositions and methods used to treat acne and candida
#19871Uracil reductase inactivators
#19872Methods and compositions for treating cancer
#19873Pharmaceutical combinations for compensating for a testosterone deficiency in men while simultaneously protecting the prostate
#19874Compositions and methods related to erythropoietin
#19875MODULATION OF NEUORGENESIS BY HDac INHIBITION
#19876Enhanced ocular neuroprotection and neurostimulation
#19877Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance
#19878Olive kernel composition containing absorption promoters, antioxidants, and anti-inflammatory agents
#19879Compositions and methods for treating and preventing virus infections
#19880Child discipline composition and method
#19881Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis
#19882Toleration iron supplement compositions
#19883Silver- and zinc- containing body care agent
#19884Methods of reducing the production of reactive oxygen species and methods of screening or identifying compounds and compositions that reduce the production of reactive oxygen species
#19885Oral compositions containing a salivation inducing agent
#19886Method and composition for pharmaceutical product
#19887Compositions and methods for improved skin care
#19888Novel compositions containing polyphenols
#19889Method of birth control and hormone regulation
#19890Drug/gene eluting stent
#19891ADMINISTRATION OF GLUTATHIONE (REDUCED) VIA INTRAVENOUS OR ENCAPSULATED IN LIPOSOME FOR THE AMELIORATION OF TNF-alpha EFFECTS AND FLU-LIKE VIRAL SYMPTOMS AND TREATMENT AND PREVENTION OF VIRUS
#19892Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
#19893Regulation of T cell-mediated immunity by tryptophan
#19894Conditioned cell culture medium compositions and methods of use
#19895Regulation of T cell-mediated immunity by tryptophan
#19896Composition and treatment for hair loss
#19897Pharmaceutical foam
#19898Hiv polynucleotides and polypeptides derived from botswana mj4
#19899Milnacipran for the long-term treatment of fibromyalgia syndrome
#19900Suppression and prevention of tumors
#19901DRONABINOL TREATMENT OF DELAYED CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
#19902Pharmaceutical composition and a method for treatment of prostate cancer
#19903NUTRITIONAL SUPPLEMENT FOR INCREASED ENERGY AND STAMINA
#199042-(3,4-dimethylphenyl)-4-{[2-hydroxy-3′-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
#19905Compositions and methods for lowering plasma concentrations of low density lipoproteins in humans
#19906Use of a pyrazole derivative for preparing medicinal products that are useful in the prevention and treatment of dyslipidaemias and of diseases related to dyslipidaemias and/or to obesity
#19907Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
#19908Method for treating drug and behavioral addictions
#19909Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
#19910Combinations of at1-antagonists, amiloride or triamterine, and a diuretic
#19911Solid peroral contraceptive preparations
#19912Bile preparations for colorectal disorders
#19913Agent for treating diabetes
#19914Antiviral compounds
#19915Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#19916Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
#19917Methods of treatment using specific binding agents of human angiopoietin-2
#19918Combination therapy for treating alphavirus infection and liver fibrosis
#19919Compositions for the treatment of atopic dermatitis, skin allergic conditions and acne
#19920Treatment of aspirin resistance with radix salviae mitiorhizae, its extract and composition
#19921Transfer factor preparations and associated methods
#19922Preparation for cardio-cerebral blood vessel diseases and its preparing method
#19923Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
#19924ORAL FORMULATION OF CREATINE DERIVATIVES AND METHOD OF MANUFACTURING SAME
#19925Ginger containing compositions to control pain
#19926Capsule filled with honey
#19927DRUGS FOR TREATING DIABETES
#19928Stable microemulsion concentrate for delivery of a bioactive biocide/disinfectant/fungicide/fragrance in an aqueous medium providing sustained release
#19929Use of RIP in treating infections
#19930Method for increasing the efficacy of anti-tumor agents by anti-endoglin antibody
#19931Method to ameliorate inflammation
#19932TREATMENT WITH ANTI-VEGF ANTIBODIES
#19933TREATMENT WITH ANTI-VEGF ANTIBODIES
#19934Purified amniotic membrane compositions and methods of use
#19935Treatment of bipolar disorder utilizing anti-fungal compositions
#19936Dermal fillers for biomedical applications in mammals and methods of using the same
#19937In Vivo Enhancement of Immune System Recognition of Neoplasms Following Treatment with an Oncolytic Virus or Gene Therapy Vector
#19938Method of treating hepatitis B viral infection
#19939TREATMENT WITH ANTI-VEGF ANTIBODIES
#19940Treatment of B cells with IL-21 and B cell activators induces Granzyme B production
#19941Method of reducing the likelihood of implantation failure during an assisted reproduction in a female subject in a need thereof
#19942Therapeutic soap product with UV protection
#19943Therapeutic soap product with UV protection
#19944Advantageous combination for inhalation of nacystelyn and bronchodilators
#19945Cytokine zalpha11 ligand fusion proteins
#19946Cytokine zalpha11 ligand fusion proteins
#19947Association between agomelatine and a thymoregulatory agent and pharmaceutical compositions containing it
#19948Methods and Compositions for the Treatment of Alopecia and Other Disorders of the Pilosebaceous Apparatus
#19949NOVEL COMPOUNDS
#19950RYANODINE RECEPTOR BLOCKERS FOR TREATING PAIN
#19951Method of treating Parkinson's Disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
#19952Inhibitors for extracellular signal-regulated kinase docking domains and uses therefor
#19953Drug delivery and targeting with vitamin B12 conjugates
#19954Vaginal compositions for treating pelvic tissue infections and traumas
#19955Methods for treating hormone associated conditions using a combination of LHRH antagonists and specific estrogen receptor modulators
#19956Compositions and methods for treatment of muscle pain and muscle wasting
#19957Methods and compositions for treating polycystic ovary syndrome
#19958Pharmaceutical composition for inducing apoptosis comprising a fusion protein between bfl-1 and green fluorescent protein or a gene encoding same
#19959Perivascular mesenchymal precursor cells
#19960METHODS FOR SHP1 MEDIATED NEUROPROTECTION
#19961Enhanced solubility of preformed calcium citrate by adding citric acid
#19962Pharmaceutical composition containing guaiacol derivatives and syringol derivatives extracted from natural plant vinegar
#19963Composition and method for treating iron deficiency anemia
#19964Mri contrast medium composition for oral administration
#19965Method of preparing sustained-release preparations of quinolone antibiotics
#19966Nutraceutical composition comprising soluble keratin or derivative thereof
#19967Composition for treating obesity comprising extract from white kidney beans, red kidney beans, and green tea leaves
#19968Encapsulated arsenic drugs
#19969Combination and method using EDTA combined with glutathione in the reduced state encapsulated in a liposome to facilitate the method of delivery of the combination as an oral, topical, intraoral or transmucosal, for anti-thrombin effect and for anti-platelet aggregation and measurement of efficacy
#19970Transdermal hormone delivery system: compositions and methods
#19971External patch containing estrogen and/or progestogen
#19972Migraine remedy
#19973Therapeutic delivery of carbon monoxide
#19974Nitric oxide gas (gO) as a cosmetic and wound healing agent
#19975Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions
#19976Nutritional supplements
#19977Method of treating cancer, especially soft tissue sarcoma utilizing gemcitabine in combination with docetaxel and anti-VEGF therapy (bevacizumab)
#19978Compositions and methods for treating hyperimmune response in the eye
#19979ANTI-CD80 ANTIBODY HAVING ADCC ACTIVITY FOR ADCC MEDIATED KILLING OF B CELL LYMPHOMA CELLS ALONE OR IN COMBINATION WITH OTHER THERAPIES
#19980Enhanced delivery of cells
#19981Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
#19982Treatment of tumor metastases and cancer
#19983Topical macqui berry formulation
#19984Compositions effective in altering the perception of malodor
#19985Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
#19986Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
#19987Association between agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing it
#19988Physiologic vaginal lubrication to optimize sperm survival and function
#19989Methods for treating lower urinary tract disorders using alpha2delta subunit calcium channel modulators with smooth muscle modulators
#19990Compositions and methods for improving functional vascular cellular survival integrity and reducing apoptosis in ischemia
#19991Therapeutic curcumin derivatives
#19992Methods and therapies for potentiating therapeutic activities of a cannabinoid receptor agonist via administration of a cannabinoid receptor antagonist
#19993Anti-cancer combinations
#19994Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
#19995Compositions and methods using proton pump inhibitors
#19996Method of Modulating Apoptosis Through Modulation of E2F1
#19997Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds
#19998Compositions and methods for inhibiting platelet activation and thrombosis
#19999Antibiotic pharmaceutical composition with lysergol as bio-enhancer and method of treatment
#20000Novel fused heterocyclic compound and use thereof
#20001Fungal and bacterial infection medication
#20002Methods and compositions employing 4-aminophenylacetic acid compounds
#20003COMBINATION THERAPIES EMPLOYING ACE INHIBITORS AND USES THEREOF FOR THE TREATMENT OF DIABETIC DISORDERS
#20004Modulation of Epac, phospholipase Cepsilon, and phospholipase D to treat pain
#20005Method for preventing vascular disease
#200062' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#20007Use of metformin and orlistat for the treatment or prevention of obesity
#20008ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS
#20009ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS
#20010ADMINISTRATION OF DIPEPTIDYL PEPTIDASE INHIBITORS
#20011Orally administered small peptides synergize statin activity
#20012Thio-containing inhibitors of aminopeptidase P, and compositions thereof
#20013Inhibition of STAT3 signal transduction for human cancer therapy
#20014Use of anti-prolactin agents to treat proliferative conditions
#20015Hsp therapy in conjunction with a low antigenicity diet
#20016Combinations of immunosupressive agents for the treatment or prevention of graft rejections
#20017Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
#20018Compositions and methods for treating bacteria
#200192' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#200202' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#200212' and 3'-nucleoside prodrugs for treating Flaviviridae infections
#20022Methods and therapies for potentiating a therapeutic action of an opioid receptor agonist and inhibiting and/or reversing tolerance to opioid receptor agonists
#200232′ and 3′-nucleoside prodrugs for treating infections
#20024Method for expanding hematopoietic cells using cytokine zalpha11 ligand
#20025Polypeptides useful for molecular weight determinations
#20026Method for determining the susceptibility of a subject to infection
#20027Composition containing ground lotus and/or lotus extract and lactic acid bacterium
#20028Antioxidant skin balm
#20029Compositions for inhibiting or reducing inflammation of skin
#20030Preventives or remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters
#20031Modular system for novel Chinese herbal formulas
#20032Therapeutic composition and method of supporting the immune system
#20033Treatment of amd with combination of ingredients
#20034Medical composition for balancing bodily processes
#20035Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity
#20036Pet life
#20037Compositions and techniques for localized therapy
#20038Methods of reducing minimal inhibitory concentration of antibiotics and compositions resulting therefrom
#20039Potent immunostimulants from microalgae
#20040Therapeutic combination compositions and methods of using same
#20041Method for generating and selecting antibodies against target protein
#20042CD37 immunotherapeutics and uses thereof
#20043COMPOUNDS AND COMPOSITIONS TO CONTROL ABNORMAL CELL GROWTH
#20044Method for administering a vaginal care composition
#20045Methods and compositions for improving visual acuity
#20046Probiotic composition having acid-resistant enteric coating
#20047Treatment for heart disease
#20048Ophthalmic compositions containing a PVA/borate gelling system
#20049Ion exchange resin treated to control swelling
#20050Compositions and methods for mitigating skin irritation
#20051Freeze-dried FSH/LH formulations
#20052Method of attenuating bruise formation
#20053Transplantation of human lipid cells and other tissue regenerative cells and methods of use ancillary to sports/entertainment/celebrity/performance employment contracts and policies insuring those contracts
#20054Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives)
#20055Factor
#20056Pharmaceutical composition comprising valsartan
#20057Association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent
#20058Inhibitors of ABC drug transporters at the blood-brain barrier
#20059Methods for the selective treatment of tumors by calcium-mediated induction of apoptosis
#20060Synergistic polyphenol compounds, compositions thereof, and uses thereof
#20061Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases
#20062Methods for treatment of headaches by administration of oxytocin
#20063Macrocyclic inhibitors of hepatitis C virus replication
#20064Cytokine zalpha11 ligand antibodies and methods of use
#20065Light-activated cation channel and uses thereof
#20066Anti-obestic composition
#20067Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases
#20068LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF
#20069Compositions for the treatment of overactive bladder
#20070Anti-inflammatory treatment
#20071Method to predict and prevent oxygen-induced inflammatory tissue injury
#20072Inhalable gaseous medicament based on xenon and nitrous oxide
#20073Novel combination of drugs as antidepressant
#20074Elastomeric gloves and methods of making
#20075Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain
#20076IL28 and IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME
#20077Combination therapy for treatment of high cholesterol
#20078Anti-αβhumanized monoclonal antibodies
#20079METHOD OF TREATING AND DIAGNOSING PARKINSONS DISEASE AND RELATED DYSAUTONOMIC DISORDERS
#20080Method of reducing immunological tolerance to malignancy
#20081Methods and kits for co-administration of nutritional supplements
#20082TREATMENT OF WOUNDS USING IL-17B
#20083Poly(potassium and sodium styrene sulfonate) its manufacture and its uses
#20084Poly(potassium and sodiumstyrene sulfonate) its manufacture and its uses
#20085Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor
#20086Cytotoxicity mediation of cells evidencing surface expression of CD44
#20087Phosphonate analogs of HIV inhibitor compounds
#20088Methods for treating and monitoring inflammation and redox imbalance cystic fibrosis
#20089Method of using ryanodine receptor antagonists to treat amyotrophic lateral sclerosis
#20090Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists
#20091Use of bh4 for the treatment of respiratory diseases
#20092Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
#20093Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same
#20094Control of induced elevated intraocular pressure
#20095Hormone replacement composition and method
#20096Methods and compositions for inhibition of angiogenesis
#20097Combination of cell necrosis inhibitor and lithium for treating neuronal death or neurological dysfunction
#20098Method for treatment or prevention of conditions caused by gram-positive bacteria
#20099Fluoroquinolone formulations and methods of making and using the same
#20100Method for enhancing mammalian immunological function